The evolution of L-dopa-induced dyskinesia in relation to L-dopa dose magnitude and frequency of administration

被引：0
|
作者：
Tsironis, C
Marselos, M
Konitsiotis, S
机构：
来源：
MOVEMENT DISORDERS | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [1] Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine
    Ye, Tony
    Bartlett, Mitchell J.
    Sherman, Scott J.
    Falk, Torsten
    Cowen, Stephen L.
    [J]. EXPERIMENTAL NEUROLOGY, 2021, 340
  • [2] L-DOPA-induced dyskinesia
    Derkinderen, P
    Vidailhet, M
    [J]. REVUE NEUROLOGIQUE, 2002, 158 : S92 - S101
  • [3] L-DOPA INDUCED DYSKINESIA
    Tursunov, D.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E94 - E94
  • [4] Dyskinesia: L-dopa-induced and tardive dyskinesia
    Rascol, O
    Fabre, N
    [J]. CLINICAL NEUROPHARMACOLOGY, 2001, 24 (06) : 313 - 323
  • [5] The pathophysiology of L-DOPA-induced dyskinesia
    Brotchie, JM
    [J]. MOVEMENT DISORDERS, 2004, 19 : S11 - S11
  • [6] Levetiracetam in L-dopa-induced dyskinesia
    Meco, G
    Fabrizio, E
    Epifanio, A
    Di Raimondo, G
    Vanacore, N
    Morgante, L
    [J]. CLINICAL NEUROPHARMACOLOGY, 2005, 28 (02) : 102 - 103
  • [7] ASSESSMENT OF L-DOPA INDUCED DYSKINESIA
    Assatullaev, G.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E103 - E103
  • [8] Molecular mechanisms of L-DOPA-induced dyskinesia
    Jenner, Peter
    [J]. NATURE REVIEWS NEUROSCIENCE, 2008, 9 (09) : 665 - 677
  • [9] Serotonergic Involvement in L-DOPA-Induced Dyskinesia
    Politis, M.
    Wu, K.
    Loane, C.
    Kiferle, L.
    Molloy, S.
    Bain, P.
    Brooks, D. J.
    Piccini, P.
    [J]. MOVEMENT DISORDERS, 2010, 25 : S658 - S659
  • [10] Opioid system in L-DOPA-induced dyskinesia
    Pan, Jing
    Cai, Huaibin
    [J]. TRANSLATIONAL NEURODEGENERATION, 2017, 6
12345